check_circleStudy Completed

Magnetic Resonance Imaging, Liver Neoplasms

MRI study of Gadovist (1.0 M ) and Magnevist with a single i.v. injection in patients with known or suspected liver lesions

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
572
Trial Dates
July 2001 - August 2002
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Gadavist/Gadovist (Gadobutrol, BAY86-4875)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Multicenter, randomized, double blind, inter-individually controlled MRI study of Gadovist (1.0 M ) and Magnevist with a single i.v. injection (0.1 mmol/kg BW) in patients with known or suspected liver lesions and with independent blinded read and assessment of the truth standard
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A